2018 - 2021 Serious skin and subcutaneous disorders caused by a sodium-glucose co-transporter 2 inhibitor, ipragliflozin
2016 - 2019 Enhancement mechanisms of cell growth suppression by bisphosphonates in cancer microenvironment
2015 - 2018 Mechanism for unpredictable drug interaction in patients with chronic kidney disease
2013 - 2016 Anticancer effects of bisphosphonates in human esophageal squamous cell
2008 - 2010 Appropriate use of the oral fluoropyrimidine anticancer drugs in patients with colorectal cancer
Show all
Papers (79):
Yusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, Ryo Shimizu, Tadashi Kosaka, Koichi Sakaguchi, Naoya Dobuchi, Kohshi Nishiguchi, Keisuke Shikata. Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy. Biological & pharmaceutical bulletin. 2023. 46. 7. 964-968
Yusuke Tabuchi, Masayuki Tsujimoto, Kosuke Yamamoto, Tadashi Kosaka, Koichi Sakaguchi, Naoya Dobuchi, Kohshi Nishiguchi, Keisuke Shikata. Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen. Cancer Chemotherapy and Pharmacology. 2023. 91. 1. 25-31
Takuya Yoshida, Masayuki Tsujimoto, Sachiyo Kawakami, Haruno Fujioka, Yuko Irie, Saki Nakatani, Ayako Iso, Ayaka Sugiyama, Mizuho Miyake, Kazumi Hirato, et al. Research on the relationship between serum indoxyl sulfate concentration and iron dynamics index in patients with end-stage kidney disease: a cross-sectional study. Renal Replacement Therapy. 2022. 8. 1
Akio Ogawa, Daiki Hira, Masayuki Tsujimoto, Kohshi Nishiguchi, Masanori Endo, Toshiaki Ono, Tsuguru Hatta, Tomohiro Terada, Shin-ya Morita. Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients Undergoing High-Flux Hemodialysis. Therapeutic Drug Monitoring. 2022. 44. 3. 396-403
Yurie Katsube, Masayuki Tsujimoto, Hiroyoshi Koide, Daiki Hira, Yoshito Ikeda, Tetsuya Minegaki, Shin-ya Morita, Tomohiro Terada, Kohshi Nishiguchi. In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver. Drug Metabolism and Disposition. 2021. 49. 4. 289-297
1989 - 1991 Kyoto Pharmaceutical University Graduate School of Pharmaceutical Sciences
1985 - 1989 Kyoto Pharmaceutical University Pharmaceutical Sciences Pharmacy
Professional career (2):
博士(薬学)京都大学
薬学修士(京都薬科大学)
Work history (4):
2008/10 - 現在 Kyoto Pharmaceutical University Department of Clinical Pharmacy Professor
2007/09 - 2008/09 Kobe University Graduate School of Medicine Associate Professor, Vice Director
2003/04 - 2007/08 Kobe University Department of Hospital Pharmacy, School of Medicine Vice Director
1991/04 - 2003/03 Kobe University Department of Hospital Pharmacy, School of Medicin Pharmacist
Association Membership(s) (5):
日本TDM学会
, 医薬品情報学会
, THE JAPANESE CANCER ASSOCIATION
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
, THE PHARMACEUTICAL SOCIETY OF JAPAN